A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
Katharina Koch(Leibniz Institute of Environmental Medicine), Ulf D. Kahlert(University Medical Center Freiburg)
Cited by 89
Related Papers
Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation
|Frontiers in Toxicology|2022|40
Alterations in cellular metabolome after pharmacological inhibition of <scp>N</scp>otch in glioblastoma cells
|International Journal of Cancer|2015|37
Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
|Oncotarget|2016|33